EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

It is Time to Address Fear of Cancer Recurrence in Family Caregivers: Feasibility and Acceptability of a Randomized Pilot Study of the Family Caregiver Version of the Fear of Recurrence Therapy (FC‐FORT)

Jani Lamarche iD, Rinat Nissim, Jonathan Avery, Jiahui Wong iD, Christine Maheu iD, Sylvie D Lambert iD, Andrea M Laizner, Jennifer Jones, Mary Jane Esplen, Sophie Lebel

Psycho-Oncology · 2025

DOI: 10.1002/pon.70084 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Psycho-Oncology, 2025. Verfasst von Jani Lamarche und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, University of Ottawa, Ottawa, Canada. Hauptthemen laut MEDLINE: Caregivers, Fear, Neoplasm Recurrence, Local, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Faculty of Social Sciences, University of Ottawa, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Fear of cancer recurrence (FCR) is common, persistent, and associated with lower quality of life, impaired functioning, and psychological distress in family caregivers (FC) of individuals with a cancer diagnosis. Interventions are needed to specifically target FCR in FC. This study aimed to pilot test the adapted Family Caregiver—Fear Of Recurrence Therapy (FC‐FORT) to establish its feasibility, acceptability, and clinical significance.

Methods

This pilot study used a mixed‐method, parallel, two‐group randomized control trial (FC‐FORT vs. waitlist control group) design. Women FC were recruited through Canadian hospitals, community partners, and social media. FC in the intervention group completed 7 weekly sessions of virtual group therapy (FC‐FORT) and an exit interview. All participants completed questionnaires at baseline, post‐intervention, and 3‐month follow‐up. Feasibility (e.g., recruitment, allocation, fidelity), acceptability (e.g., dropout, completion, satisfaction) and clinical significance of secondary outcomes were evaluated. Descriptive statistics, mixed ANOVAs, and conventional content analyses were used.

Results

Regarding feasibility, 22 FC were recruited, 18 were randomized and therapist fidelity was 87%. As to acceptability, 67% of participants completed 5 sessions (33% dropout). Questionnaire completion rate was 92%. FC satisfaction was 80%. Analyses did not reveal any significant differences on the secondary outcomes between groups. Qualitative analyses revealed high importance, helpfulness, satisfaction, and group cohesion. Suggestions were made by FC for improvements.

Conclusions

This is one of the first interventions to address FCR in FC. While acceptability of FC‐FORT was good, important feasibility issues need to be addressed before moving forward with a larger randomized control trial. Trial Registration NCT, NCT05441384. Registered July 1st, 2022, https://classic.clinicaltrials.gov/ct2/show/NCT05441384

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaregiversFearNeoplasm Recurrence, LocalNeoplasmsHumansFemalePilot ProjectsMiddle AgedFeasibility StudiesAdultMaleAgedQuality of LifePatient Acceptance of Health CareSurveys and Questionnaires

Stichwörter der Autor:innen

acceptabilitycancercaregiversfear of cancer recurrencefeasibilitypilot study

Autor:innen und Institutionen

  • School of Psychology, University of Ottawa, Ottawa, Canada.
  • Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
  • Temerty Faculty of Medicine, Department of Psychiatry, University of Toronto, Toronto, Canada.
  • Cancer Chat, de Souza Institute, Toronto, Canada.
  • Ingram School of Nursing, McGill University, Montreal, Canada.
  • St. Mary's Research Centre, St. Mary's Hospital Center, Montreal, Canada.

ORCID-Profile: Jani Lamarche, Jiahui Wong, Christine Maheu, Sylvie D Lambert

Förderung

  • CIHR
  • Faculty of Social Sciences, University of Ottawa
  • Canadian Institutes of Health Research

Zitieren

APA

Lamarche, J., Nissim, R., Avery, J., Wong, J., Maheu, C., Lambert, S. D., Laizner, A. M., Jones, J., Esplen, M. J., & Lebel, S. (2025). It is Time to Address Fear of Cancer Recurrence in Family Caregivers: Feasibility and Acceptability of a Randomized Pilot Study of the Family Caregiver Version of the Fear of Recurrence Therapy (FC‐FORT). Psycho-Oncology. https://doi.org/10.1002/pon.70084

Vancouver

Lamarche J, Nissim R, Avery J, Wong J, Maheu C, Lambert SD, et al. It is Time to Address Fear of Cancer Recurrence in Family Caregivers: Feasibility and Acceptability of a Randomized Pilot Study of the Family Caregiver Version of the Fear of Recurrence Therapy (FC‐FORT). Psycho-Oncology. 2025. doi:10.1002/pon.70084

BibTeX
@article{Lamarche2025,
  author = {Lamarche, Jani and Nissim, Rinat and Avery, Jonathan and Wong, Jiahui and Maheu, Christine and Lambert, Sylvie D and Laizner, Andrea M and Jones, Jennifer and Esplen, Mary Jane and Lebel, Sophie},
  title = {It is Time to Address Fear of Cancer Recurrence in Family Caregivers: Feasibility and Acceptability of a Randomized Pilot Study of the Family Caregiver Version of the Fear of Recurrence Therapy (FC‐FORT)},
  journal = {Psycho-Oncology},
  year = {2025},
  doi = {10.1002/pon.70084}
}
Kostenlos starten →